Pharma Mar S.A.
PHM | MC
Overview
Corporate Details
- ISIN(s):
- ES0169501022 (+1 more)
- LEI:
- 959800QWKZ45ZQC2AV58
- Country:
- Spain
- Address:
- Avenida de los Reyes 1 Polígono Industrial La Mina, 28770 Colmenar Viejo
- Website:
- https://pharmamar.com/en/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
PharmaMar is a fully integrated Spanish biotech/pharmaceutical. Born in 1986, the company takes its inspiration for discovery of oncology medicines from the sea. We are inspired by the sea, driven by science, and motivated by patients with serious diseases to improve their lives by delivering novel medicines to them. We intend to continue to be the world leader in marine medicinal discovery, development and innovation. 90% of all drugs entering clinical trials fail to gain approval. With a first approval in 2007, and a third drug approved by 2020, our hypothesis and platform technology have been validated. To get 3 drugs approved is something under 1% of biotech companies achieve. We are in the 1%.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-19 00:00 |
Directors' Dealings
Motivo de la notificación: Persona con Responsabilidad de Dirección
|
Spanish | 91.4 KB | |
| 2025-06-18 00:00 |
Declaration of Voting Results & Voting Rights Announcements
Se informa que todas las propuestas de acuerdos presentadas por el Consejo a la…
|
Spanish | 389.6 KB | |
| 2025-06-18 00:00 |
General Meeting Notice
Se remite copia de la presentación a accionistas que será realizada en la Junta…
|
Spanish | 2.5 MB | |
| 2025-06-09 00:00 |
Directors' Dealings
Motivo de la notificación: Persona con Responsabilidad de Dirección
|
Spanish | 91.4 KB | |
| 2025-06-09 00:00 |
Directors' Dealings
Motivo de la notificación: Persona con Responsabilidad de Dirección
|
Spanish | 91.4 KB | |
| 2025-06-05 00:00 |
Directors' Dealings
Motivo de la notificación: Persona con Responsabilidad de Dirección
|
Spanish | 91.4 KB | |
| 2025-05-26 17:41 |
Transaction in Own Shares
La Sociedad informa de las operaciones llevadas a cabo al amparo del Programa d…
|
Spanish | 171.3 KB | |
| 2025-05-23 00:00 |
Directors' Dealings
Motivo de la notificación: Persona con Responsabilidad de Dirección
|
Spanish | 91.4 KB | |
| 2025-05-22 00:00 |
Directors' Dealings
Motivo de la notificación: Persona Estrechamente Vinculada
|
Spanish | 91.4 KB | |
| 2025-05-21 08:27 |
Regulatory News Service
La Sociedad presenta la solicitud en la UE para comercializar lurbinectedina en…
|
Spanish | 744.9 KB | |
| 2025-05-19 17:40 |
Transaction in Own Shares
La Sociedad informa de las operaciones llevadas a cabo al amparo del Programa d…
|
Spanish | 183.1 KB | |
| 2025-05-19 08:26 |
Regulatory News Service
La Sociedad anuncia que su socio Adium Pharma S.A. ha recibido la aprobación pa…
|
Spanish | 751.5 KB | |
| 2025-05-13 00:00 |
Directors' Dealings
Motivo de la notificación: Persona con Responsabilidad de Dirección
|
Spanish | 91.4 KB | |
| 2025-05-12 17:38 |
Transaction in Own Shares
La Sociedad informa de las operaciones llevadas a cabo al amparo del Programa d…
|
Spanish | 165.2 KB | |
| 2025-05-06 11:42 |
General Meeting Notice
La Sociedad remite anuncio de convocatoria de la Junta General Ordinaria de Acc…
|
Spanish | 495.5 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |